Prisma Biotechnology
PrivateCompany Overview
Prisma Biotechnology is a biotechnology company that develops a protein sequencing platform designed to unveil functional drivers of biology and transform human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
protein sequencingproteomicsdrug discoverysingle-molecule sequencingbiotech instrumentationde novo sequencingpost-translational modificationslife science toolsnext-gen proteomicsprotein analysisbiomarker discoveryomics platformdeep proteomicslab-on-a-chip
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prisma Biotechnology Comparables
Compare Prisma Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glyphic Biotechnologies | 89% | |
| Erisyon | 88% | |
| Encodia | 83% | |
Prisma Biotechnology Funding Rounds
Historical fundraising activity
Prisma Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prisma Biotechnology's valuation, stock price, and market status.
Firmographic Details
HeadquartersSomerville, Massachusetts
Employee Range7
Year Founded2021
Last Funding—
See something wrong or outdated?